XML 32 R20.htm IDEA: XBRL DOCUMENT v3.20.4
Business Segments and Geographic Information
 3 Months Ended
Dec. 26, 2020
Segment Reporting [Abstract]  
Business Segments and Geographic Information Business Segments and Geographic InformationDuring the first fiscal quarter of 2021, the Company had four reportable segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health. During the first fiscal quarter of 2020, the Company had five reportable segments that included Medical Aesthetics. The Company completed the sale of its Medical Aesthetics business on December 30, 2019. The Company measures and evaluates its reportable segments based on segment revenues and operating income adjusted to exclude the effect of non-cash charges, such as intangible asset amortization expense, intangible asset and goodwill impairment charges, transaction and integration expenses for acquisitions, restructuring, consolidation and divestiture charges, litigation charges, and other one-time or unusual items.
Identifiable assets for the reportable segments consist of inventories, intangible assets, goodwill, and property, plant and equipment. The Company fully allocates depreciation expense to its reportable segments. The Company has presented all other identifiable assets as corporate assets. There were no inter-segment revenues during the three months ended December 26, 2020 and December 28, 2019. Segment information is as follows:
 Three Months Ended
 December 26,
2020		December 28,
2019
Total revenues:
Diagnostics$1,128.2 $311.5 
Breast Health332.7 331.1 
GYN Surgical124.0 119.1 
Skeletal Health24.9 23.5 
Medical Aesthetics— 65.3 
$1,609.8 $850.5 
Income from operations:
Diagnostics$784.5 $49.5 
Breast Health86.3 93.9 
GYN Surgical13.7 31.5 
Skeletal Health1.0 0.9 
Medical Aesthetics— (51.0)
$885.5 $124.8 
Depreciation and amortization:
Diagnostics$56.3 $59.1 
Breast Health13.1 10.0 
GYN Surgical23.2 21.0 
Skeletal Health0.2 0.2 
Medical Aesthetics— 4.1 
$92.8 $94.4 
Capital expenditures:
Diagnostics$38.3 $18.1 
Breast Health2.9 6.4 
GYN Surgical3.3 5.3 
Skeletal Health— 0.1 
Medical Aesthetics— 1.4 
Corporate0.3 0.2 
$44.8 $31.5 
 
December 26,
2020		September 26,
2020
Identifiable assets:
Diagnostics$2,177.8 $2,161.4 
Breast Health1,203.4 1,200.9 
GYN Surgical1,418.5 1,438.7 
Skeletal Health31.3 38.9 
Corporate2,719.7 2,355.9 
$7,550.7 $7,195.8 
The Company had no customers that represented greater than 10% of consolidated revenues during the three months ended December 26, 2020 and December 28, 2019.
The Company operates in the following major geographic areas noted in the below chart. Revenue data is based upon customer location. Other than the United States, no single country accounted for more than 10% of consolidated revenues. The Company’s sales in Europe are predominantly derived from France, the United Kingdom and Germany. The Company’s sales in Asia-Pacific are predominantly derived from China, Australia and Japan. The “Rest of world” designation includes Canada, Latin America and the Middle East.
Revenues by geography as a percentage of total revenues were as follows:
 
 Three Months Ended
 December 26,
2020		December 28,
2019
United States70.7 %74.4 %
Europe21.0 %12.9 %
Asia-Pacific5.5 %8.3 %
Rest of World2.8 %4.4 %
100.0 %100.0 %